Barclays Raises Quest Diagnostics’ Price Target to $185 From $175

Real-time Estimate Cboe BZX			5-day change	1st Jan Change
172.74 ^USD	+6.72%		+2.49%	+14.14%

April 22, 2025 at 02:42 pm EDT

This article is reserved for members

Unlock the article: REGISTER NOW!

Barclays Raises Quest Diagnostics’ Price Target to $185 From $175	02:42pm	MT
Evercore ISI Adjusts Quest Diagnostics Price Target to $180 From $175	01:55pm	MT
Leerink Adjusts Price Target on Quest Diagnostics to $189 From $184	12:10pm	MT
Sector Update: Health Care Stocks Rise Pre-Bell Tuesday	09:23am	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Focus on Earnings Reports	08:32am	MT
Quest Diagnostics Incorporated, Q1 2025 Earnings Call, Apr 22, 2025	08:30am
Quest beats quarterly profit estimates on strong demand for diagnostic tests	07:36am	RE
Quest Diagnostics Q1 Adjusted Earnings, Revenue Increase; 2025 Adjusted Earnings Outlook Affirmed	07:08am	MT
(DGX) Quest Diagnostics Expects 2025 Net Revenue Range $10.70B – $10.85B, vs. FactSet Est of $10.78B	06:55am	MT
(DGX) Quest Diagnostics Expects Full Year 2025 Adjusted EPS Range $9.55 – $9.80, vs. FactSet Est of $9.68	06:55am	MT
Earnings Flash (DGX) Quest Diagnostics Reports Q1 Revenue $2.65B, vs. FactSet Est of $2.63B	06:55am	MT
Earnings Flash (DGX) Quest Diagnostics Posts Q1 Adjusted EPS $2.21, vs. FactSet Est of $2.15	06:55am	MT
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025	06:45am	CI
Quest Diagnostics Launches New AD- Detect Blood Test to Aid in Confirming Alzheimer’s Disease	Apr. 09	CI
Quest Diagnostics- Introduces Hpv Specimen Self-Collection For Cervical Cancer Screening	Apr. 02	RE
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening	Apr. 02	CI
Redburn Atlantic Initiates Quest Diagnostics at Buy With $195 Price Target	Apr. 02	MT
Nephron Research Downgrades Quest Diagnostics to Hold From Buy, $184 Price Target	Mar. 27	MT
Baird Adjusts Price Target on Quest Diagnostics to $191 From $190, Keeps Outperform Rating	Mar. 20	MT
Quest Diagnostics Incorporated – Analyst/Investor Day	Mar. 19
Quest Diagnostics Lowers Q1 Outlook, Reaffirms 2025 Guidance	Mar. 19	MT
Quest Diagnostics Incorporated Provides Earnings Guidance for the First Quarter of 2025 and Reaffirms Earnings Guidance for the Year 2025	Mar. 19	CI
Quest Diagnostics Announces to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI	Mar. 18	CI
Baird Adjusts Price Target on Quest Diagnostics to $190 From $189, Maintains Outperform Rating	Mar. 17	MT
Quest Diagnostics Incorporated : Your health comes first	Mar. 04

Duration

Period

DGX: Dynamic Chart

Quest Diagnostics Incorporated is the world’s leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:

– testing and diagnostic services (97%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;

– other (3%).

More about the company

Sell

Buy

Last Close Price

161.86USD

Average target price

179.27USD

Spread / Average Target

+10.75%

Consensus

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Bit Digital Exits Bitcoin Mining for $44M Ethereum Staking Strategy

Will GameStop Buy More Bitcoin? GME Boosts Latest Fundraise to $2.7 Billion

Bit Digital Inc. Announces Strategic Shift to Ethereum Treasury and Staking Operations

BTC Spot ETF Demand Proves Bitcoin Is A Macro Asset

Why Did Solana and Ethereum Treasury Stocks Plunge on Routine SEC Filings?

Bitcoin Has Rallied 10% Since Sunday As Geopolitical Tensions Cool

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Bit Digital Exits Bitcoin Mining for $44M Ethereum Staking Strategy

Will GameStop Buy More Bitcoin? GME Boosts Latest Fundraise to $2.7 Billion

Bit Digital Inc. Announces Strategic Shift to Ethereum Treasury and Staking Operations

BTC Spot ETF Demand Proves Bitcoin Is A Macro Asset

Why Did Solana and Ethereum Treasury Stocks Plunge on Routine SEC Filings?

Bitcoin Has Rallied 10% Since Sunday As Geopolitical Tensions Cool

Barclays Raises Quest Diagnostics’ Price Target to $185 From $175

Related Posts

Bit Digital Exits Bitcoin Mining for $44M Ethereum Staking Strategy

Will GameStop Buy More Bitcoin? GME Boosts Latest Fundraise to $2.7 Billion

Bit Digital Inc. Announces Strategic Shift to Ethereum Treasury and Staking Operations

US stocks drop as Trump escalates Fed attack. Tariff fears also weigh

Bitcoin Demand Momentum Drops 642K BTC as ETF Inflows Dry Up: CryptoQuant — TradingView News

Top Cryptocurrencies Rise; Bitcoin Tops $91,000

Recent Posts

Navigate Site

Barclays Raises Quest Diagnostics’ Price Target to $185 From $175

Related Posts

Recent Posts

Navigate Site

Follow Us